VolitionRX Ltd ( VNRX) - Key Metrics
VNRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.04 | -$0.80 | -$0.56 | -$0.56 |
| 2026Q1 | $0.14 | -$0.97 | -$0.77 | -$0.77 |
| 2025Q4 | $0.08 | -$1.17 | -$1.03 | -$1.03 |
| 2025Q3 | $0.12 | -$0.99 | -$0.64 | -$0.64 |
| 2025Q2 | $0.08 | -$1.22 | -$1.22 | -$1.24 |
VNRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.40 |
| 2026Q1 | 0% | -1.04 |
| 2025Q4 | 0% | -1.22 |
| 2025Q3 | 0% | -3.40 |
| 2025Q2 | 0% | -3.10 |
VNRX
Price: $0.34
52 week price:
Earnings Per Share: -3.96 USD
Exchange: ASE
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 202636
Market Capitalization: 6.7 million